MDT

95.89

+0.39%↑

VEEV

287.37

+0.14%↑

A

139.11

+1.87%↑

HQY

92.25

+1.85%↑

PHR.US

21.97

-1.57%↓

MDT

95.89

+0.39%↑

VEEV

287.37

+0.14%↑

A

139.11

+1.87%↑

HQY

92.25

+1.85%↑

PHR.US

21.97

-1.57%↓

MDT

95.89

+0.39%↑

VEEV

287.37

+0.14%↑

A

139.11

+1.87%↑

HQY

92.25

+1.85%↑

PHR.US

21.97

-1.57%↓

MDT

95.89

+0.39%↑

VEEV

287.37

+0.14%↑

A

139.11

+1.87%↑

HQY

92.25

+1.85%↑

PHR.US

21.97

-1.57%↓

MDT

95.89

+0.39%↑

VEEV

287.37

+0.14%↑

A

139.11

+1.87%↑

HQY

92.25

+1.85%↑

PHR.US

21.97

-1.57%↓

Search

Pacific Biosciences of California Inc

Abrir

SetorSaúde

1.49 5.67

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.41

Máximo

1.49

Indicadores-chave

By Trading Economics

Rendimento

384M

-42M

Vendas

2.6M

40M

Margem de lucro

-105.442

Funcionários

575

EBITDA

367M

-36M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+40.14% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

39M

457M

Abertura anterior

-4.18

Fecho anterior

1.49

Sentimento de Notícias

By Acuity

50%

50%

158 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Pacific Biosciences of California Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de out. de 2025, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Caterpillar to Acquire Australia's RPM Global for $730 Million

10 de out. de 2025, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Strathcona Resources Terminates Take-Over Bid for MEG Energy

12 de out. de 2025, 23:47 UTC

Conversa de Mercado

Gold Rises, Buoyed by Monetary Debasement Fears -- Market Talk

12 de out. de 2025, 23:39 UTC

Conversa de Mercado

Oil Rises on Likely Technical Recovery, Mildly Positive Sentiment -- Market Talk

12 de out. de 2025, 23:22 UTC

Conversa de Mercado

New Zealand Braces For Renewed Trade War Uncertainty -- Market Talk

12 de out. de 2025, 23:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Caterpillar Inc. Enters Into Agreement To Acquire RPMGlobal >CAT RUL.AU

12 de out. de 2025, 22:32 UTC

Conversa de Mercado

Copper, U.S. Thermal Coal Stand Out as Metals Ride Macro Tailwinds -- Market Talk

12 de out. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

RPM Global Says Board Unanimously Recommends Shareholders Accept Caterpillar Offer

12 de out. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

RPM Global Agrees to Takeover by Caterpillar

12 de out. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

RPM Global Says Caterpillar Offering A$5.00/Share in Cash

11 de out. de 2025, 08:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

11 de out. de 2025, 00:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Why Biotech May Be Back -- Barrons.com

10 de out. de 2025, 21:07 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Dell Is Just Beginning to Tell Its AI Story. Buy the Stock. -- Barrons.com

10 de out. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

10 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

10 de out. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

10 de out. de 2025, 20:06 UTC

Conversa de Mercado

Fed Won't Publish Monthly Industrial Data Next Week -- Market Talk

10 de out. de 2025, 20:06 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 de out. de 2025, 19:56 UTC

Conversa de Mercado

U.S.-China Tension Weighs Down on Treasury Yields, Dollar -- Market Talk

10 de out. de 2025, 19:20 UTC

Conversa de Mercado

Oil Futures Sink As Trump Rekindles Trade Tensions -- Market Talk

10 de out. de 2025, 19:02 UTC

Conversa de Mercado

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

10 de out. de 2025, 18:58 UTC

Conversa de Mercado

Canada's Jobs Gain Marks a 'Head Fake' For Economy -- Market Talk

10 de out. de 2025, 18:52 UTC

Conversa de Mercado

PepsiCo Lays Groundwork for Improvement -- Market Talk

10 de out. de 2025, 18:47 UTC

Conversa de Mercado

Precious Metals Turn Higher After Profit-Taking Slide -- Market Talk

10 de out. de 2025, 18:35 UTC

Conversa de Mercado

Canada's Next Rate Cut May be Pushed to December -- Market Talk

10 de out. de 2025, 18:31 UTC

Conversa de Mercado

Canada's Labor Market Firming. But Conditions Vary Across Country -- Market Talk

10 de out. de 2025, 17:32 UTC

Conversa de Mercado

U.S. Oil Rig Count Declines by Four to 418 -- Market Talk

10 de out. de 2025, 16:55 UTC

Ganhos

These Stocks Are Moving the Most Today: MP Materials, Nvidia, Alibaba, Venture Global, Applied Digital, Qualcomm, and More -- Barrons.com

10 de out. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

10 de out. de 2025, 16:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

Comparação entre Pares

Variação de preço

Pacific Biosciences of California Inc Previsão

Preço-alvo

By TipRanks

40.14% parte superior

Previsão para 12 meses

Média 1.99 USD  40.14%

Máximo 3 USD

Mínimo 1.25 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Pacific Biosciences of California Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

3

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.13 / N/ASuporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

158 / 371 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
help-icon Live chat